TELUS Health and McGill University have entered into a three-year, million dollar partnership to create a learning environment and conduct research on how best to use technology to improve health and healthcare delivery for Canadians. This joint partnership with McGill is the second for TELUS Health, demonstrating once again that industry and academic communities can collaborate to produce independent, evidence-based research, in order to help address challenges that the Canadian healthcare system is facing.
Investment In a Quebec Public-Private Partnership to Support the Use of Personalized Medicine Solutions in the Treatment of Cancer Patients
The Government of Québec announced today a $10 million investment in the Personalized Medicine Partnership for Cancer (PMPC). This public-private partnership will be focused on establishing an integrated approach for the development and implementation of clinical biomarkers and other personalized healthcare solutions to improve the outcome and cost-efficiency of healthcare services provided to cancer patients in the province of Québec and abroad.